Lofentanil is an analog of fentanyl and is one of the most potent opioids available today. It displays most similarity to carfentanil (4-carbomethoxyfentanyl) and is considered to be slightly more potent than this drug.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Buprenorphine | Lofentanil may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine. |
| Doxylamine | Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Lofentanil. |
| Dronabinol | Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Lofentanil. |
| Droperidol | Droperidol may increase the central nervous system depressant (CNS depressant) activities of Lofentanil. |
| Hydrocodone | Lofentanil may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone. |
| Hydroxyzine | Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Lofentanil. |
| Magnesium sulfate | The therapeutic efficacy of Lofentanil can be increased when used in combination with Magnesium sulfate. |
| Methotrimeprazine | Lofentanil may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine. |
| Metyrosine | Lofentanil may increase the sedative activities of Metyrosine. |
| Minocycline | Minocycline may increase the central nervous system depressant (CNS depressant) activities of Lofentanil. |
| Nabilone | Nabilone may increase the central nervous system depressant (CNS depressant) activities of Lofentanil. |
| Orphenadrine | Lofentanil may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine. |
| Paraldehyde | Lofentanil may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde. |
| Perampanel | Perampanel may increase the central nervous system depressant (CNS depressant) activities of Lofentanil. |
| Pramipexole | Lofentanil may increase the sedative activities of Pramipexole. |
| Ropinirole | Lofentanil may increase the sedative activities of Ropinirole. |
| Rotigotine | Lofentanil may increase the sedative activities of Rotigotine. |
| Rufinamide | The risk or severity of adverse effects can be increased when Rufinamide is combined with Lofentanil. |
| Sodium oxybate | Lofentanil may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Suvorexant | Lofentanil may increase the central nervous system depressant (CNS depressant) activities of Suvorexant. |
| Tapentadol | Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Lofentanil. |
| Thalidomide | Lofentanil may increase the central nervous system depressant (CNS depressant) activities of Thalidomide. |
| Zolpidem | Lofentanil may increase the central nervous system depressant (CNS depressant) activities of Zolpidem. |
| Alvimopan | The risk or severity of adverse effects can be increased when Lofentanil is combined with Alvimopan. |
| Desmopressin | The risk or severity of hyponatremia can be increased when Lofentanil is combined with Desmopressin. |
| Morphine | The risk or severity of adverse effects can be increased when Morphine is combined with Lofentanil. |
| Codeine | The risk or severity of adverse effects can be increased when Codeine is combined with Lofentanil. |
| Hydromorphone | The risk or severity of adverse effects can be increased when Hydromorphone is combined with Lofentanil. |
| Meperidine | The risk or severity of adverse effects can be increased when Meperidine is combined with Lofentanil. |
| Oxycodone | The risk or severity of adverse effects can be increased when Oxycodone is combined with Lofentanil. |
| Dextropropoxyphene | The risk or severity of adverse effects can be increased when Dextropropoxyphene is combined with Lofentanil. |
| Naltrexone | The therapeutic efficacy of Lofentanil can be decreased when used in combination with Naltrexone. |
| Sufentanil | The risk or severity of adverse effects can be increased when Sufentanil is combined with Lofentanil. |
| Alfentanil | The risk or severity of adverse effects can be increased when Alfentanil is combined with Lofentanil. |
| Fentanyl | The risk or severity of adverse effects can be increased when Fentanyl is combined with Lofentanil. |
| Levorphanol | The risk or severity of adverse effects can be increased when Levorphanol is combined with Lofentanil. |
| Remifentanil | The risk or severity of adverse effects can be increased when Remifentanil is combined with Lofentanil. |
| Diphenoxylate | The risk or severity of adverse effects can be increased when Diphenoxylate is combined with Lofentanil. |
| Oxymorphone | The risk or severity of adverse effects can be increased when Oxymorphone is combined with Lofentanil. |
| Dezocine | The risk or severity of adverse effects can be increased when Dezocine is combined with Lofentanil. |
| Methadyl acetate | The risk or severity of adverse effects can be increased when Methadyl acetate is combined with Lofentanil. |
| Dihydroetorphine | The risk or severity of adverse effects can be increased when Dihydroetorphine is combined with Lofentanil. |
| Diamorphine | The risk or severity of adverse effects can be increased when Diamorphine is combined with Lofentanil. |
| Bezitramide | The risk or severity of adverse effects can be increased when Bezitramide is combined with Lofentanil. |
| Ethylmorphine | The risk or severity of adverse effects can be increased when Ethylmorphine is combined with Lofentanil. |
| Etorphine | The risk or severity of adverse effects can be increased when Etorphine is combined with Lofentanil. |
| Dextromoramide | The risk or severity of adverse effects can be increased when Dextromoramide is combined with Lofentanil. |
| Desomorphine | The risk or severity of adverse effects can be increased when Desomorphine is combined with Lofentanil. |
| Carfentanil | The risk or severity of adverse effects can be increased when Carfentanil is combined with Lofentanil. |
| Dihydrocodeine | The risk or severity of adverse effects can be increased when Dihydrocodeine is combined with Lofentanil. |
| Alphacetylmethadol | The risk or severity of adverse effects can be increased when Alphacetylmethadol is combined with Lofentanil. |
| Dihydromorphine | The risk or severity of adverse effects can be increased when Dihydromorphine is combined with Lofentanil. |
| Ketobemidone | The risk or severity of adverse effects can be increased when Ketobemidone is combined with Lofentanil. |
| DPDPE | The risk or severity of adverse effects can be increased when DPDPE is combined with Lofentanil. |
| Opium | The risk or severity of adverse effects can be increased when Lofentanil is combined with Opium. |
| Normethadone | The risk or severity of adverse effects can be increased when Lofentanil is combined with Normethadone. |
| Piritramide | The risk or severity of adverse effects can be increased when Lofentanil is combined with Piritramide. |
| Alphaprodine | The risk or severity of adverse effects can be increased when Lofentanil is combined with Alphaprodine. |
| Nicomorphine | The risk or severity of adverse effects can be increased when Lofentanil is combined with Nicomorphine. |
| Meptazinol | The therapeutic efficacy of Lofentanil can be decreased when used in combination with Meptazinol. |
| Phenoperidine | The risk or severity of adverse effects can be increased when Lofentanil is combined with Phenoperidine. |
| Phenazocine | The risk or severity of adverse effects can be increased when Lofentanil is combined with Phenazocine. |
| Tilidine | The risk or severity of adverse effects can be increased when Lofentanil is combined with Tilidine. |
| Carfentanil, C-11 | The risk or severity of adverse effects can be increased when Lofentanil is combined with Carfentanil, C-11. |
| Naloxegol | The risk or severity of adverse effects can be increased when Naloxegol is combined with Lofentanil. |
| Benzhydrocodone | The risk or severity of adverse effects can be increased when Lofentanil is combined with Benzhydrocodone. |
| Pegvisomant | The therapeutic efficacy of Pegvisomant can be decreased when used in combination with Lofentanil. |
| Succinylcholine | The risk or severity of bradycardia can be increased when Succinylcholine is combined with Lofentanil. |
| Methadone | The risk or severity of adverse effects can be increased when Methadone is combined with Lofentanil. |
| Linezolid | The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Lofentanil. |
| Mirtazapine | Lofentanil may increase the serotonergic activities of Mirtazapine. |
| Fluvoxamine | The risk or severity of serotonin syndrome can be increased when Lofentanil is combined with Fluvoxamine. |
| Citalopram | The risk or severity of serotonin syndrome can be increased when Lofentanil is combined with Citalopram. |
| Duloxetine | The risk or severity of serotonin syndrome can be increased when Lofentanil is combined with Duloxetine. |
| Paroxetine | The risk or severity of serotonin syndrome can be increased when Lofentanil is combined with Paroxetine. |
| Sertraline | The risk or severity of serotonin syndrome can be increased when Lofentanil is combined with Sertraline. |
| Sibutramine | The risk or severity of serotonin syndrome can be increased when Lofentanil is combined with Sibutramine. |
| Nefazodone | The risk or severity of serotonin syndrome can be increased when Lofentanil is combined with Nefazodone. |
| Zimelidine | The risk or severity of serotonin syndrome can be increased when Lofentanil is combined with Zimelidine. |
| Dapoxetine | The risk or severity of serotonin syndrome can be increased when Lofentanil is combined with Dapoxetine. |
| Milnacipran | The risk or severity of serotonin syndrome can be increased when Lofentanil is combined with Milnacipran. |
| Desvenlafaxine | The risk or severity of serotonin syndrome can be increased when Desvenlafaxine is combined with Lofentanil. |
| Seproxetine | The risk or severity of serotonin syndrome can be increased when Lofentanil is combined with Seproxetine. |
| Levomilnacipran | The risk or severity of serotonin syndrome can be increased when Lofentanil is combined with Levomilnacipran. |
| Indalpine | The risk or severity of serotonin syndrome can be increased when Lofentanil is combined with Indalpine. |
| Ritanserin | The risk or severity of serotonin syndrome can be increased when Lofentanil is combined with Ritanserin. |
| Alaproclate | The risk or severity of serotonin syndrome can be increased when Lofentanil is combined with Alaproclate. |
| Ethanol | Lofentanil may increase the central nervous system depressant (CNS depressant) activities of Ethanol. |
| Azelastine | Lofentanil may increase the central nervous system depressant (CNS depressant) activities of Azelastine. |
| Brimonidine | Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Lofentanil. |
| Phentermine | Phentermine may increase the analgesic activities of Lofentanil. |
| Pseudoephedrine | Pseudoephedrine may increase the analgesic activities of Lofentanil. |
| Benzphetamine | Benzphetamine may increase the analgesic activities of Lofentanil. |
| Diethylpropion | Diethylpropion may increase the analgesic activities of Lofentanil. |
| Lisdexamfetamine | The risk or severity of serotonin syndrome can be increased when Lofentanil is combined with Lisdexamfetamine. |
| Mephentermine | Mephentermine may increase the analgesic activities of Lofentanil. |
| MMDA | MMDA may increase the analgesic activities of Lofentanil. |
| Midomafetamine | Midomafetamine may increase the analgesic activities of Lofentanil. |
| 2,5-Dimethoxy-4-ethylamphetamine | 2,5-Dimethoxy-4-ethylamphetamine may increase the analgesic activities of Lofentanil. |
| 4-Bromo-2,5-dimethoxyamphetamine | 4-Bromo-2,5-dimethoxyamphetamine may increase the analgesic activities of Lofentanil. |